Search research articles
Contact Us
Filters
Showing results (141-150 of 236) with videos related to
Page
of 24
Sort By:
International Journal of Environmental Research and Public Health
|
July 24, 2021
Energy Drink Consumption among Adolescents Attending Schools in Lubumbashi, Democratic Republic of Congo
Trésor Carsi Kuhangana, Taty Muta Musambo, Joseph Pyana Kitenge, et al.
Haematologica
|
March 15, 2006
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
Sophie Ducastelle, Lionel Adès, Claude Gardin, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
November 5, 2011
CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry
Françoise Solly, Fanny Angelot, Richard Garand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database
Philippe Solal-Céligny, Monica Bellei, Luigi Marcheselli, et al.
American Journal of Hematology
|
May 26, 2020
Impact of detectable measurable residual disease on umbilical cord blood transplantation
Frédéric Baron, Myriam Labopin, Annalisa Ruggeri, et al.
Journal of Clinical Medicine
|
July 8, 2020
Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
Thomas Rogier, Maxime Samson, Guillaume Mourey, et al.
Experimental Hematology & Oncology
|
March 4, 2016
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
Clémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Experimental Hematology & Oncology
|
April 16, 2016
Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
Clémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2005
Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang study
Eric Deconinck, Mathilde Hunault, Noël Milpied, et al.
Transplantation
|
March 20, 2013
Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies
Vanderson Rocha, Myriam Labopin, Annalisa Ruggeri, et al.
Page
of 24
Search research articles
Search
Showing results (141-150 of 236) with videos related to
Sort By:
Page
of 24
International Journal of Environmental Research and Public Health
|
July 24, 2021
Energy Drink Consumption among Adolescents Attending Schools in Lubumbashi, Democratic Republic of Congo
Trésor Carsi Kuhangana, Taty Muta Musambo, Joseph Pyana Kitenge, et al.
Haematologica
|
March 15, 2006
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
Sophie Ducastelle, Lionel Adès, Claude Gardin, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
November 5, 2011
CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry
Françoise Solly, Fanny Angelot, Richard Garand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database
Philippe Solal-Céligny, Monica Bellei, Luigi Marcheselli, et al.
American Journal of Hematology
|
May 26, 2020
Impact of detectable measurable residual disease on umbilical cord blood transplantation
Frédéric Baron, Myriam Labopin, Annalisa Ruggeri, et al.
Journal of Clinical Medicine
|
July 8, 2020
Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
Thomas Rogier, Maxime Samson, Guillaume Mourey, et al.
Experimental Hematology & Oncology
|
March 4, 2016
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
Clémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Experimental Hematology & Oncology
|
April 16, 2016
Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
Clémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2005
Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang study
Eric Deconinck, Mathilde Hunault, Noël Milpied, et al.
Transplantation
|
March 20, 2013
Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies
Vanderson Rocha, Myriam Labopin, Annalisa Ruggeri, et al.
Page
of 24